Baron & Budd Attorney and Shareholder Burton LeBlanc to Speak on Opioid Epidemic at American Association for Justice
BATON ROUGE, La. – November 17, 2017 – The national law firm of Baron & Budd is pleased to...READ MORE
It starts with a small problem. Four little letters, perhaps the most used acronym in elementary schools around the country: ADHD. Your son had a problem with paying attention in class, maybe he was fidgety, rambunctious, maybe he had small outbursts after being told to sit in class like the rest of the them. Oh yes, the rest of them. You see, your son was like them before. In retrospect, really, he was. His problems with ADHD were not anything worth huge concern. Instead, it was a sort of normal issue.
Who would have known that the medicine prescribed to treat his sort of normal ADHD problem would have such catastrophic consequences: The development of male breasts — at the worst possible time, adolescence, that time of bullying and school cliques galore — that do not go away without surgery.
It started out with a little problem, a sort of normal issue with ADHD. Before you knew it, that little problem became huge. Now it is not just paying attention in class and small problems with behavior and fidgeting or what have you, now it’s a larger issue of being left out, of being made fun of, of not being understood — and all of those issues, well, they contribute to a mess of a problem, one where a lack of confidence can lead to a sea of real and really very big issues. Small problems with attention can lead to huge problems with anger management, for instance, when an adolescent boy experiences something as devastating to his self-confidence and self-acceptance as this.
But why? After all, there are other drugs out there that can be prescribed to treat ADHD, drugs that do not come with the potentially severe side effect of male breast development.
The answer is simple — and frustrating: Risperdal is overprescribed for ADHD because it was marketed to doctors and patients as a treatment option for behavioral problems before it was even approved for the adolescent age group. It was not a careless mistake; it was improper marketing that had devastating consequences. What’s more, it was improper marketing that they thought they could get away with –selling a prescription drug to young boys who already have problems. Well, that’s an easy audience — young adolescent boys and children with behavioral problems, if they complain or make a fuss, if they do not improve or if they even get worse on the drug, well who is to tell if it’s the drug’s fault or if the boys’ complaints are true?
It’s a twisted fortune that, thanks to the male breast development, we can see that Risperdal is not a proper drug to prescribe to adolescent boys with less severe behavioral problems. Because the male breast development is something that we cannot deny.
Luckily, there is a way to speak up against the inappropriate marketing of Risperdal. It’s called the Risperdal lawsuit and we are here to go over your options and help you decide if you would like to file a lawsuit.
If you or your child developed male breasts while taking Risperdal, we may be able to help you file a Risperdal lawsuit to help you pay for the breast removal surgery.